EARLY OUTCOMES OF RADICAL SURGERY FOR GASTRIC CANCER TREATMENT AT 19-8 HOSPITAL

Nam Long Trần, Minh Tuấn Nguyễn, Đình Hợp Nguyễn, Đức Thành Lò

Main Article Content

Abstract

Objective: To describe the clinical and paraclinical characteristics, and to evaluate the early outcomes, feasibility, safety, and effectiveness of radical surgery in the treatment of gastric cancer at 19-8 Hospital. Subjects and Methods: A retrospective and prospective descriptive study of 35 patients who underwent radical surgery for gastric cancer at 19-8 Hospital from July 2021 to July 2025. Results: The study included 35 patients: 25 males (71.4%) and 10 females (28.6%), with a male-to-female ratio of 2.5:1. The mean age was 61.7 ± 11.9 years (range: 30–84). The most common tumor location was the distal third of the stomach (62.9%). Subtotal gastrectomy was performed in 32 cases (91.4%), and total gastrectomy in 3 cases (8.6%). The mean operative time was 182.17 ± 19.35 minutes (range: 145–240). The majority of digestive tract reconstructions were Roux-en-Y (94.3%). No intraoperative complications or postoperative mortality were observed. A total of 731 lymph nodes were dissected, with an average of 20.88 ± 8.69 nodes per patient (range: 12–46); among them, 123 metastatic nodes were found, accounting for 16.82%. The postoperative complication rate was 8.6%, including one case requiring reoperation due to early bowel obstruction. The average postoperative hospital stay was 12.25 ± 2.82 days (range: 7–19). Conclusion: Radical surgery for gastric cancer at 19-8 Hospital is a safe technique that has shown good preliminary results and provides high treatment efficacy for patients.

Article Details

References

Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin. 2021 May;71(3):209–249. doi:10.3322/caac.21660.
2. Trịnh Hồng Sơn. Nghiên cứu nạo vét hạch trong điều trị ung thư dạ dày Luận án Tiến sĩ Y học. Hà Nội: Trường Đại học Y Hà Nội; 2001.
3. Nguyễn Đức Huân. Nghiên cứu đặc điểm lâm sàng, mô bệnh học và hóa mô miễn dịch của ung thư dạ dày tại Bệnh viện K. Luận văn Bác sĩ nội trú. Hà Nội: Đại học Y Hà Nội; 2006.
4. Everett SM, Raxon AT. Early gastric cancer in Europe. Gut. 1997;41:142–150.
5. Roh C, Choi S, Seo W, et al. Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: experience of 14,075 patients from a large volume centre. Eur J Surg Oncol. 2021 Feb 25.
6. Andreollo NA, Lopes LR, Coelho Neto JS. Postoperative complications after total gastrectomy in the gastric cancer: analysis of 300 patients. ABCD Arq Bras Cir Dig. 2011;24:126–130.
7. Sano T, Coit DG, Kim HH, et al. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer. 2017;20:
8. Kikuchi S, Sakasibara Y, Sakuramuto S, et al. Recent results in the surgical treatment of gastric cancer according to the Japanese and TNM classification. Anticancer Res. 2001;48(1):1227–1230